-
What Does Jazz Pharma's Latest FDA Approval Mean?
Thursday, March 31, 2016 - 10:32am | 218Read More...The US FDA granted marketing approval for Defitelio® [defibrotide sodium] for the treatment of adult and pediatric patients with hepatic VOD, also known as sinusoidal obstruction syndrome [SOS], with renal or pulmonary dysfunction following HSCT. Jazz Pharmaceuticals plc - Ordinary Shares (...
-
Allegations Mallinckrodt Is Hiking Acthar Prices Called 'False'
Wednesday, March 16, 2016 - 3:55pm | 302Read More...In a new report, Northland Capital Markets analyst David Buck reiterates the firm’s bullish take on Mallinckrodt PLC (NYSE: MNK), despite unfavorable comparisons to the crashing Valeant Pharmaceuticals Intl Inc (NYSE: VRX) in recent days. The CNBC appearance by CEO Mark Trudeau on Tuesday...
-
Northland Starts Jazz Pharma, Mallinckrodt, Shire With Outperform Ratings
Wednesday, October 14, 2015 - 9:36am | 531Read More...David Buck of Northland Capital Markets initiated coverage of Jazz Pharmaceuticals plc (NASDAQ: JAZZ), Mallinckrodt PLC (NYSE: MNK), and Shire PLC (ADR) (NASDAQ: SHPG) with Outperform ratings. Buck is positive on the long-term revenue prospect of the three names. Buck noted all three...
